At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 153 enrolled
Drug / intervention
Oral insulindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2b, Open-label Randomized Comparative Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects Uncontrolled With Metformin Hydrochloride Treatment
In Brief
A Phase 2 clinical trial evaluating Oral insulin for Type 2 Diabetes Treated With Insulin. Completed, enrolled 153 participants across 1 site.
Detailed Summary
The aim of the study was to compare the pharmacodynamic properties of different doses of regular human insulin administered in capsule form twice daily in a randomised twelve-week open-label trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Treated With Insulin
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 2CompletedFinished
20192020202120222023202420252026
Enrollment StartOct 2018
Primary CompletionJul 2020
First PostedJun 2024
TodayJul 2026
First PostedJun 25, 2024
Enrollment StartOct 22, 2018
Primary CompletionJul 11, 2020
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 2.0 years ago
Interventions
Oral insulindrug
Capsule administered by mouth with a glass of water two times per day, once before breakfast and once before supper